1. Home
  2. BHAT vs ENSC Comparison

BHAT vs ENSC Comparison

Compare BHAT & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BHAT

Blue Hat Interactive Entertainment Technology

HOLD

Current Price

$1.15

Market Cap

59.1M

ML Signal

HOLD

Logo Ensysce Biosciences Inc.

ENSC

Ensysce Biosciences Inc.

HOLD

Current Price

$0.90

Market Cap

6.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHAT
ENSC
Founded
2010
2003
Country
China
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.1M
6.3M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
BHAT
ENSC
Price
$1.15
$0.90
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
101.1K
443.4K
Earning Date
05-12-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$18,972,415.00
$4,487,973.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.51
52 Week Low
$1.07
$0.86
52 Week High
$24.50
$9.57

Technical Indicators

Market Signals
Indicator
BHAT
ENSC
Relative Strength Index (RSI) 34.65 22.39
Support Level $1.11 $0.86
Resistance Level $1.39 $1.24
Average True Range (ATR) 0.12 0.10
MACD -0.02 -0.01
Stochastic Oscillator 8.16 7.72

Price Performance

Historical Comparison
BHAT
ENSC

About BHAT Blue Hat Interactive Entertainment Technology

Blue Hat Interactive Entertainment Technology is focused on commodity trading, including chemicals, jewelry, and precious metals such as gold. It operates a gold and diamond trading and supply chain business. Its business model encompasses physical gold trading, diamond trading, gold derivatives trading, and the development of AI-enabled trading platforms. Its segments include Diamond trading, Commodity trading, Information service, Interactive toys - animation series, and Interactive toys - game series. It derives revenue from Diamond trading. The majority of its revenues are generated in PRC.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: